Hims & Hers Health Inc Down 6.90% To $6.21 After Earnings Miss

Tuesday, August 9, 2022 - Hims & Hers Health Inc (HIMS) reported downside earnings and upside revenues.

Hims & Hers Health Inc's earnings came in at an EPS loss of $0.1 per share, 11% lower than estimates for an EPS loss of $0.09 per share. The firm's loss per share expanded by 100% since reporting a loss of $0.05 per share a year ago. Remember, earnings reported were on an adjusted basis, so they may not be comparable to prior reports and/or analyst estimates.

Consensus estimates for Hims & Hers Health Inc revenue averaged out to $103.9 million, with the business managing to beat those expectations with reported second-quarter revenue of $113.6 million. The $9.7 million (9%) positive revenue surprise led to 87% growth year-over-year as the firm reported revenue of $60.7 million in its year-ago quarter. The lower earnings growth compared to revenue points to Hims & Hers Health Inc not being able to improve its profit margin.

The stock is down 6.90% to $6.21 after the report.

The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.

Wall Street Analysts had an average rating of Hold on the stock prior to the report.

InvestorsObserver gives the stock a Bullish Sentiment score at the moment based on recent trading.

Prior to the report, InvestorsObserver gave the stock an overall score of 63. Meanwhile, the average Wall Street analyst rated the stock a Hold.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.